Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Women and their families are encouraged to come along to a public open day, on Tuesday 24th May, about research into the health of women and babies. During the event you can listen to talks and meet the teams who are involved in gynaecology, pregnancy and reproduction research.

OSPREA (Oxford Safer Pregnancy Alliance) is a team of doctors, scientists, researchers, midwives, nurses and support staff who are working together with women and their families to carry out research relating to pregnancy and reproduction.  Along with Gynaecology research colleagues they will be hosting a free open day for the public to come along and find out more about the range of research and the latest findings into women's reproductive health.

The event runs from 12.00 - 16.000 and refreshments will be available. Presentations will cover both obstetrics and gynaecology research studies as well as the experiences of research participants.  For more detailed information about the event programme visit

All are welcome and if you would like to attend, please register your interest at:  or, you can also drop in on the day.  

About OSPREA: The OSPREA Research Unit is a dedicated centre based in the John Radcliffe Hospital, Oxford, staffed by an experienced team of research midwives and doctors. We are primarily supported by the Nuffield Department of Obstetrics and Gynaecology, part of the University of Oxford, the Oxford University Hospitals NHS Foundation Trust and the Thames Valley CRN, part of the National Institute for Health Research.

The Oxford Safer Pregnancy  Alliance

Similar stories

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

Varicose veins are a very common manifestation of chronic venous disease, affecting over 30% of the population in Western countries. In America, chronic venous disease affects over 11 million men and 22 million women aged 40–80 years old. Left untreated it can escalate to multiple health complications including leg ulcers and ultimately amputations. A new international study by Oxford researchers published on 2nd June 2022 in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.

New imaging study could make diagnosing endometriosis quicker, more accurate and reduce the need for invasive surgery.

A new research study launches to investigate whether a 20-minute imaging scan can detect the most common types of endometriosis, which currently require surgery to diagnose.

Oxford researchers part of major UK initiative to understand chronic pain

Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.

Dawes-Redman Education awarded funds from Huntleigh Healthcare

The Dawes-Redman Education programme which offers virtual CTG Analysis training sessions to Obstetric consultants, antenatal and student midwifes has received generous funds from Huntleigh Healthcare for the next 3 years.

Endometriosis: pandemic backlog risks making it even harder for women to get help

The COVID-19 pandemic has had a disproportionate and devastating impact on women’s health, according to a report from the Royal College of Obstetricians and Gynaecologists.

Diagnostic test could offer new hope for ME/CFS patients

Myalgic Encephalomyelitis /Chronic Fatigue Syndrome (ME/CFS) is a chronic condition without a diagnostic test and some 80 - 90% of patients remain un-diagnosed. A new paper published in Frontiers in Medicine outlines how having a diagnostic test could greatly help both patients and medics.